Literature DB >> 9576757

Dual implication of 2',3'-cyclic nucleotide 3' phosphodiesterase as major autoantigen and C3 complement-binding protein in the pathogenesis of multiple sclerosis.

M J Walsh1, J M Murray.   

Abstract

Multiple sclerosis (MS) is characterized by intra-blood-brain barrier immunoglobulin synthesis that persists lifelong. Subcellular fractionation and two-dimensional electrophoresis were used in conjunction with immune precipitation and immunoblotting to identify antigenic determinants for this immunoglobulin. We report that 2', 3'-cyclic nucleotide 3'-phosphodiesterase (CNP), a protein associated with oligodendrocyte/myelin membranes, also present in lymphocytes and retina, is one major target for the humoral response. Antibodies to CNP are detected in sera of 74% of MS patients. The antibodies are IgM and are present in serum in high titer as well as in cerebrospinal fluid. The antibody response is temporally persistent, consistent with systemic immune activation and persistent antigenic stimulation. Moreover, CNP is isolated as an immune complex from MS brain. CNP is expressed as two isoforms, with CNPII identical to CNPI but with a 20-amino acid extension at the amino terminus of CNPII; however, the antibody response is exclusively restricted to CNPI. In contrast, both isoforms bind the C3 complement, providing a plausible mechanism in MS central nervous system (CNS) for opsonization of myelin membrane CNP, mediated via the C3 receptor, and phagocytosis of CNP-Ig immune complexes, mediated by membrane Ig Fc receptors of macrophages and CNS microglia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9576757      PMCID: PMC508779          DOI: 10.1172/JCI1983

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  57 in total

1.  A study of the crystalline albumin, gamma globulin and total protein in the cerebrospinal fluid of 100 cases of multiple sclerosis and in other diseases.

Authors:  E A KABAT; D A FREEDMAN
Journal:  Am J Med Sci       Date:  1950-01       Impact factor: 2.378

2.  Molecular cloning of a 2',3'-cyclic nucleotide 3'-phosphodiesterase: mRNAs with different 5' ends encode the same set of proteins in nervous and lymphoid tissues.

Authors:  L Bernier; F Alvarez; E M Norgard; D W Raible; A Mentaberry; J G Schembri; D D Sabatini; D R Colman
Journal:  J Neurosci       Date:  1987-09       Impact factor: 6.167

3.  Immunoglobulin G, A, and M--clonal restriction in multiple sclerosis cerebrospinal fluid and serum--analysis by two-dimensional electrophoresis.

Authors:  M J Walsh; W W Tourtellotte; J Roman; W Dreyer
Journal:  Clin Immunol Immunopathol       Date:  1985-06

4.  In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis.

Authors:  D A Hafler; D A Fox; M E Manning; S F Schlossman; E L Reinherz; H L Weiner
Journal:  N Engl J Med       Date:  1985-05-30       Impact factor: 91.245

5.  Reference values for CSF-IgM, CSF-IgM/S-IgM ratio and IgM index, and its application to patients with multiple sclerosis and aseptic meningoencephalitis.

Authors:  P Forsberg; A Henriksson; H Link; S Ohman
Journal:  Scand J Clin Lab Invest       Date:  1984-02       Impact factor: 1.713

6.  Activation of complement by myelin: identification of C1-binding proteins of human myelin from central nervous tissue.

Authors:  P Vanguri; M L Shin
Journal:  J Neurochem       Date:  1986-05       Impact factor: 5.372

7.  Simultaneous measurement of 2':3' cyclic-nucleotide 3' phosphodiesterase and RNase activities in sera and spinal fluids of multiple sclerosis patients.

Authors:  P A Clapshaw; H W Müller; H Wiethölter; W Seifert
Journal:  J Neurochem       Date:  1984-01       Impact factor: 5.372

8.  Lymphocytotoxic antibodies in family members of patients with multiple sclerosis.

Authors:  A L Schocket; H L Weiner
Journal:  Lancet       Date:  1978-03-18       Impact factor: 79.321

9.  Deposition of C3b and iC3b onto particulate activators of the human complement system. Quantitation with monoclonal antibodies to human C3.

Authors:  S L Newman; L K Mikus
Journal:  J Exp Med       Date:  1985-06-01       Impact factor: 14.307

10.  Temporal invariance and clonal uniformity of brain and cerebrospinal IgG, IgA, and IgM in multiple sclerosis.

Authors:  M J Walsh; W W Tourtellotte
Journal:  J Exp Med       Date:  1986-01-01       Impact factor: 14.307

View more
  17 in total

Review 1.  Humoral immunity in multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis.

Authors:  Anne H Cross; Jennifer L Stark
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 2.  B-cells and humoral immunity in multiple sclerosis. Implications for therapy.

Authors:  Sangjin Oh; Cornelia Cudrici; Takahiro Ito; Horea Rus
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

3.  Expression, purification, and initial characterization of different domains of recombinant mouse 2',3'-cyclic nucleotide 3'-phosphodiesterase, an enigmatic enzyme from the myelin sheath.

Authors:  Matti Myllykoski; Petri Kursula
Journal:  BMC Res Notes       Date:  2010-01-21

Review 4.  The myelin membrane-associated enzyme 2',3'-cyclic nucleotide 3'-phosphodiesterase: on a highway to structure and function.

Authors:  Arne Raasakka; Petri Kursula
Journal:  Neurosci Bull       Date:  2014-05-07       Impact factor: 5.203

Review 5.  Autoimmune antigenic targets at the node of Ranvier in demyelinating disorders.

Authors:  Panos Stathopoulos; Harry Alexopoulos; Marinos C Dalakas
Journal:  Nat Rev Neurol       Date:  2015-01-27       Impact factor: 42.937

6.  Role of CNPase in the oligodendrocytic extracellular 2',3'-cAMP-adenosine pathway.

Authors:  Jonathan D Verrier; Travis C Jackson; Delbert G Gillespie; Keri Janesko-Feldman; Rashmi Bansal; Sandra Goebbels; Klaus-Armin Nave; Patrick M Kochanek; Edwin K Jackson
Journal:  Glia       Date:  2013-08-06       Impact factor: 7.452

Review 7.  B cells in multiple sclerosis.

Authors:  Mark P Burgoon; Donald H Gilden; Gregory P Owens
Journal:  Front Biosci       Date:  2004-01-01

8.  Protein array-based profiling of CSF identifies RBPJ as an autoantigen in multiple sclerosis.

Authors:  Luis Querol; Pamela L Clark; Mary A Bailey; Chris Cotsapas; Anne H Cross; David A Hafler; Steven H Kleinstein; Jae-Yun Lee; Gur Yaari; Simon N Willis; Kevin C O'Connor
Journal:  Neurology       Date:  2013-08-06       Impact factor: 9.910

9.  Alpha actinin is specifically recognized by Multiple Sclerosis autoantibodies isolated using an N-glucosylated peptide epitope.

Authors:  Shashank Pandey; Ilaria Dioni; Duccio Lambardi; Feliciana Real-Fernandez; Elisa Peroni; Giulia Pacini; Francesco Lolli; Roberta Seraglia; Anna Maria Papini; Paolo Rovero
Journal:  Mol Cell Proteomics       Date:  2012-11-08       Impact factor: 5.911

10.  Anti-DNA antibodies are a major component of the intrathecal B cell response in multiple sclerosis.

Authors:  R A Williamson; M P Burgoon; G P Owens; O Ghausi; E Leclerc; L Firme; S Carlson; J Corboy; P W Parren; P P Sanna; D H Gilden; D R Burton
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.